Imerys (NK) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Dec, 2025Executive summary
Q1 2025 revenue reached €871 million, representing 0.7% organic growth at constant scope and exchange rates, marking the fourth consecutive quarter of organic growth despite weak European industrial markets.
Adjusted EBITDA was €128 million, up 4% year-over-year, driven by Performance Minerals and Graphite & Carbon, but impacted by lower joint venture contributions compared to an exceptional Q1 2024.
Net income group share after non-recurring expenses was €23 million, down sharply year-over-year due to lower JV contributions and asset disposals.
March was the strongest month of the quarter, with a positive trajectory expected to continue.
Sustainability initiatives advanced, including the first biodiversity report and a major US Power Purchase Agreement supporting decarbonization goals.
Financial highlights
Revenue for Q1 2025: €871 million (+0.7% organic growth year-over-year); sequential revenue improved 4.7% from Q4 2024.
Adjusted EBITDA margin was 14.7%, down from 20.2% in Q1 2024.
Current operating income was €56 million; current net income group share was €31 million.
Perimeter effect of -€68 million due to paper business divestiture; positive FX effect of €6 million.
Organic sales growth driven by resilient volumes (-0.7%) and price increases (+1.4%).
Outlook and guidance
No formal guidance provided; management expects continued growth if volumes hold and no major recession occurs.
Direct impact from new or increased tariffs expected to be very limited due to local production and minimal interregional flows.
Macroeconomic and geopolitical uncertainty expected to persist, with a focus on resilience and local production capabilities.
Commitment to responsible, profitable growth and decarbonization remains unchanged.
Latest events from Imerys
- Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Strong 2024 results, higher dividend, strategic progress, and all resolutions approved.NK
AGM 20253 Feb 2026 - H1 2024 adjusted EBITDA rose 11% to €384m, margin 20%, with strong cash flow and guidance.NK
H1 20242 Feb 2026 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 202417 Jan 2026 - Organic growth, margin expansion, and strong ESG progress with robust 2025 outlook.NK
H2 202415 Dec 2025 - Stable H1 2025 sales and EBITDA, but net income fell; full-year EBITDA guidance reaffirmed.NK
Q2 202516 Nov 2025 - Revenue down 0.7% YTD; cost controls and strategic growth moves support profitability.NK
Q3 20251 Nov 2025